NCT01349920 Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143) Status COMPLETED Phase N/A
NCT01348880 Vardenafil ODT (Orally Disintegrating Tablet) - Nifedipine Interaction Study Status COMPLETED Phase PHASE1
NCT01344746 Leukotrienes Pathway in Chinese Children With Sleep-disordered Breathing Status UNKNOWN Phase N/A
NCT01343641 Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects Status WITHDRAWN Phase PHASE2
NCT01343485 Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series Status COMPLETED Phase NA
NCT01343407 A Two-part Study of the Effects of MK-1029 in Allergen-Challenged Asthmatics (MK-1029-003) Status COMPLETED Phase PHASE1
NCT01341639 Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) Status COMPLETED Phase PHASE3
NCT01340937 A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006) Status COMPLETED Phase PHASE3
NCT01340768 Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262) Status COMPLETED Phase PHASE3
NCT01340573 Evaluating Safety and Efficacy In Hepatitis C Patients After PegIntron Pen Treatment (Study P04896) Status TERMINATED Phase N/A
NCT01338051 The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru Status COMPLETED Phase PHASE1
NCT01337674 Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010) Status COMPLETED Phase PHASE1
NCT01337167 Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005) Status COMPLETED Phase PHASE3
NCT01336322 Metformin and Sitagliptin in Women With Previous Gestational Diabetes Status COMPLETED Phase PHASE2
NCT01335997 Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143) Status TERMINATED Phase PHASE3
NCT01335607 A Open-label Study to Evaluate the Relative Bioavailability of Samatasvir (IDX184) and Food Effect in Healthy Male Participants (MK-2355-006) Status COMPLETED Phase PHASE1
NCT01335529 Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin Status COMPLETED Phase PHASE2
NCT01335230 The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients Status COMPLETED Phase N/A
NCT01334229 Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01334086 Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy Status COMPLETED Phase PHASE2